Effect of Stillingia Sylvatica Versus Homoeopathic Individual medicines in the Reduction of Symptom Severity of Rheumatoid Arthritis

Effect of STILLINGIA SYLVATICA Versus Homoeopathic Constitutional medicines in the Reduction of Symptom Severity of RHEUMATOID ARTHRITIS-A Prospective Open Label Double Arm Study - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059776

Enrollment

Registered

2023-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M056- Rheumatoid arthritis with involvement of other organs and systems

Interventions

Intervention1: Stillingia Sylvatica: Stillingia Sylvatica mother tincture - 5 drops three times daily for 3 weeks/ Stillingia Sylvatica 30c/ 200c -3 doses weekly one dose for 3 weeks Control Interven

Eligibility

Inclusion criteria

Inclusion criteria: 1. Those patients satisfying 2010 ACR/EULAR criteria for Rheumatoid Arthritis. 2. Subjects belonging to both sexes. 3. Patients belonging to the age group 20-70 years.

Exclusion criteria

Exclusion criteria: 1. Cases associated with malignancies, severe illnesses like renal failure, hepatic failure. 2. Pregnant females. 3. Cases with disease activity score 28 value more than 7.5(high disease activity)

Design outcomes

Primary

Measure	Time frame
Disease Activity Score 28 final value - Disease Activity Score 28 initial value with Stillingia Sylvatica and Constitutional Medicine. Timepoint: Interval for 3 months duration	—

Secondary

Measure	Time frame
To compare the effect of Stillingia sylvatica to homoeopathic individualized medicines in rheumatoid arthritis patients among the two groups.Timepoint: After 1 year (After completion of the study)	—

Countries

India

Contacts

Public ContactDr Candy Benny

Kerala University of Health Sciences

drmayabj@gmail.com9544306474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026